SUBSCRIBE
SUBSCRIBE

Biogen

NEWS
Deals
Biogen Is Hunting For Neuroscience Deals Of All Sizes
July 26, 2017
 · 
1 min read
Investors Sigh With Relief as Biogen's Alzheimer's Drug Delivers in Early-Stage Study
Job Trends
Biogen May Cut Jobs, Shutter Facilities to Streamline Ops and Free Up $400 Million for R&D
July 25, 2017
 · 
3 min read
How Biogen Makes Most of Its Cash
Genetown
How Biogen Makes Most of Its Cash
July 14, 2017
 · 
3 min read
Business
Big Expectations For Biogen’s New VP Of Governmental Affairs
July 12, 2017
 · 
1 min read
Drug Development
Why Biogen Spinoff Bioverativ’s Anemia Drug Could Be A Blockbuster
July 11, 2017
 · 
1 min read
Genetown
Liver Safety Issues Lead The EMA To Restrict Biogen’s MS Drug
July 10, 2017
 · 
1 min read
Why This Biotech, Up 300% Since May, Could be the Next Big M&A Target
Deals
What Makes Biogen and Bristol-Myers Squibb Such Attractive Takeover Targets
June 27, 2017
 · 
3 min read
Genetown
Alzheimer’s Drug Leads UBS To Upgrade Biogen
June 21, 2017
 · 
1 min read
Investors Sigh With Relief as Biogen's Alzheimer's Drug Delivers in Early-Stage Study
Business
Biogen Brings Ex-Shire Exec Into C-Suite
June 20, 2017
 · 
2 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
JOBS
IN THE PRESS
Press Releases
Ionis completes enrollment in pivotal cohort of the Phase 3 REVEAL study evaluating obudanersen in Angelman syndrome
July 6, 2026
 · 
6 min read
Press Releases
Samsung Bioepis Relaunches BYOOVIZ® (ranibizumab-nuna) in the United States in Partnership with Harrow
July 1, 2026
 · 
8 min read
Press Releases
Biogen to Highlight Breadth of Alzheimer’s Disease Portfolio at AAIC 2026, Including Phase 2 CELIA Data for Diranersen
June 29, 2026
 · 
13 min read
Press Releases
Biogen Expands Immunology Pipeline with Agreement to Acquire RayThera Inc.
June 18, 2026
 · 
8 min read
Press Releases
New Progress Toward Public Reimbursement of SKYCLARYS™ for People Living with Friedreich Ataxia in Quebec
June 8, 2026
 · 
4 min read
Press Releases
FNIH Names Recipients of the 2026 Charles A. Sanders, MD, Partnership Award
June 4, 2026
 · 
3 min read
Press Releases
Biogen’s Salanersen Receives FDA Breakthrough Therapy Designation for Spinal Muscular Atrophy
June 4, 2026
 · 
13 min read
Press Releases
EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control in Systemic Lupus Erythematosus
June 4, 2026
 · 
18 min read
Press Releases
Biogen Announces Upcoming Kidney Presentations at European Renal Association and American Transplant Congresses
June 3, 2026
 · 
20 min read
Press Releases
UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 Study Results in Systemic Lupus Erythematosus
June 1, 2026
 · 
16 min read
Load More